Synta Pharmaceuticals Corp (NASDAQ:SNTA)

Data as of --
-- -- / --
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Synta Pharmaceuticals Corp. discovers, develops and commercializes novel pharmaceutical products. It is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with cancer and other severe medical conditions. Its lead drug candidate, ganetespib, is a next generation Hsp90 inhibitor in Phase 3 development for non-small cell lung cancer and in a broad development program including clinical trials for breast cancer, ovarian cancer and acute myeloid leukemia. In addition, the company developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA.

Contact Information

Synta Pharmaceuticals Corp.
45 Hartwell Avenue
Lexington Massachusetts 02421
P:(781) 274-8200
Investor Relations:
(781) 541-7250



Other institutional38.83%
Individual stakeholders37.71%
Mutual fund holders12.53%

Top Executives

Anne C. WhitakerPresident, Chief Executive Officer & Director
Chen SchorChief Operating Officer & Executive Vice President
Marc R. SchneebaumChief Financial Officer & Senior Vice President
Vojo VukovicChief Medical Officer & Senior Vice President
Iman El-HariryVice President-Clinical Research

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.